Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

medRxiv : the preprint server for health sciences·2026
Same author

HIV, HPV, and oral health in Tanzania: a scoping review.

Infectious agents and cancer·2026
Same author

Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.

iScience·2026
Same author

Trends in Coronavirus Disease 2019 Mortality Within a US Academic Health System, 2020-2025.

Open forum infectious diseases·2026
Same author

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.

Vaccine·2026
Same author

Improved understanding of pulmonary Mycobacterium avium treatment will arise from focusing on patients.

Annals of the American Thoracic Society·2026

Related Experiment Video

Updated: Jun 3, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Discriminating between latent and active tuberculosis with multiple biomarker responses.

Marc Frahm1, Neela D Goswami, Kouros Owzar

  • 1Center for AIDS Research, Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Tuberculosis (Edinburgh, Scotland)
|March 12, 2011
PubMed
Summary

Biomarker responses, including Interleukin-15 (IL-15) and Monocyte Chemoattractant Protein-1 (MCP-1), can help diagnose tuberculosis infection and differentiate between active and latent disease. These biomarkers show promise for improved tuberculosis diagnostics.

Related Experiment Videos

Last Updated: Jun 3, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Tuberculosis (TB) diagnosis and differentiation between active and latent infection remain challenging.
  • Novel biomarkers are needed to improve diagnostic accuracy and clinical management of TB.

Purpose of the Study:

  • To identify specific biomarker responses to TB antigens for improved diagnosis.
  • To differentiate between active and latent TB infections using biomarker profiles.

Main Methods:

  • Simultaneous evaluation of 25 biomarkers in whole blood supernatants using Luminex Multiplexed Bead Array.
  • Stimulation of blood samples with Quantiferon(®) Gold In-Tube kit antigens and a negative control.
  • Analysis of biomarker responses, defining response as the difference between antigen and control stimulation.

Main Results:

  • Interferon-gamma-induced protein 10 (IP-10) was significantly higher in TB-infected individuals (active or latent) versus uninfected controls.
  • Interleukin-15 (IL-15) and Monocyte Chemoattractant Protein-1 (MCP-1) levels were significantly higher in active TB compared to latent TB.
  • A combination of IL-15 and MCP-1 accurately identified 83% of active and 88% of latent TB infections.

Conclusions:

  • IL-15 and MCP-1 show potential as biomarkers for distinguishing active from latent TB infection.
  • These biomarkers could aid in the diagnosis and management of tuberculosis.
  • Further validation is warranted to confirm the clinical utility of IL-15 and MCP-1 in TB diagnostics.